专题报道:乳腺肿瘤

循环肿瘤细胞联合乳管镜影像系统提高血性乳头溢液患者恶性病变的诊断效能

  • 罗云昭 ,
  • 李杰 ,
  • 张超
展开
  • 首都医科大学附属北京朝阳医院乳腺外科 (北京 100020 )

收稿日期: 2023-06-19

  网络出版日期: 2023-12-11

基金资助

首都医科大学本科生科研创新项目(XSKY2023243)

CTC combined with ductoscopy imaging system can improve the diagnostic efficiency of malignant lesions in patients with bloody nipple discharge

  • Yunzhao LUO ,
  • Jie LI ,
  • Chao. ZHANG
Expand
  • Department of Breast Surgery,Beijing Chaoyang Hospital,Capital Medical University,Chaoyang District,Beijing 100020,China

Received date: 2023-06-19

  Online published: 2023-12-11

摘要

目的 探讨循环肿瘤细胞(CTC)联合乳管镜影像系统提高血性乳头溢液患者恶性病变诊断效能的效果。 方法 回顾性分析2019年9月至2023年6月首都医科大学附属北京朝阳医院120例血性乳头溢液患者的临床资料,所有患者均行外周血CTC、乳管镜影像系统检查。以病理结果为金标准,判断CTC、乳管镜影像系统单独及联合检查时对血性乳头溢液患者恶性病变的诊断效能。 结果 120例患者病理结果显示良性病变88例,恶性病变32例;恶性病变组CTC计数为1(0.5,2.5)个/3.2 mL,高于良性病变组的0(0,1)个/3.2 mL(P < 0.001);ROC曲线显示,CTC 计数诊断血性乳头溢液患者恶性病变的最佳截断值为2个/3.2 mL,共检出良性病变103例,恶性病变17例;乳管镜检查检出良性病变77例,恶性病变43例;以病理结果为金标准,CTC对血性乳头溢液患者恶性病变的诊断敏感度、特异度、准确度、阳性预测值、阴性预测值分别为46.88%、97.73%、84.17%、88.24%、83.50%,乳管镜检查分别为84.38%、81.82%、82.50%、62.79%、93.51%,CTC与乳管镜联合检查分别为96.88%、81.82%、85.83%、65.96%、98.63%。 结论 CTC联合乳管镜影像系统检查对血性乳头溢液患者恶性病变的诊断效能较高。

本文引用格式

罗云昭 , 李杰 , 张超 . 循环肿瘤细胞联合乳管镜影像系统提高血性乳头溢液患者恶性病变的诊断效能[J]. 实用医学杂志, 2023 , 39(22) : 2909 -2913 . DOI: 10.3969/j.issn.1006-5725.2023.22.009

Abstract

Objective To investigate the effect of circulating tumor cells (CTCS) combined with ductoscopy imaging system to improve the diagnostic efficiency of malignant lesions in patients with bloody nipple discharge. Methods Clinical data of 120 patients with bloody nipple discharge in our hospital from September 2019 to June 2023 were retrospectively analyzed, and all patients underwent peripheral blood CTC and ductoscopy. With pathological results as the gold standard, the diagnostic efficacy of CTC and ductoscopy in the diagnosis of malignant lesions in patients with bloody nipple discharge alone and in combination is evaluated. Results Pathological results of 120 patients showed benign lesions in 88 cases and malignant lesions in 32 cases. The count of CTCS in malignant lesion group was 1(0.5, 2.5)cells/3.2 mL, higher than that in benign lesion group 0(0, 1)cells/3.2 mL(P < 0.001). ROC curve showed that the best cutoff value of CTC count for the diagnosis of malignant lesions in patients with bloody nipple discharge was 2 cells /3.2 mL. A total of 103 benign lesions and 17 malignant lesions were detected. 77 benign lesions and 43 malignant lesions were detected by ductoscopy imaging system. Using pathological results as the gold standard, the diagnostic sensitivity, specificity, accuracy, positive predictive value and negative predictive value of CTC for malignant lesions in patients with bloody nipple discharge were 46.88%, 97.73%, 84.17%, 88.24% and 83.50%, respectively. 84.38%, 81.82%, 82.50%, 62.79%, 93.51% for ductoscopy, and 96.88%, 81.82%, 85.83%, 65.96%, 98.63% for CTC combined with ductoscopy. Conclusion The diagnosis of malignant lesions in patients with bloody nipple discharge by CTC combined with ductoscopic imaging system is more effective.

参考文献

1 卢小华, 吴永晓, 张涛, 等. 病理性乳头溢液患者的临床特征及其癌变风险预测模型的构建[J]. 广西医学, 2021, 43(15):1816-1821.
2 LAM N C, TRAN J. Unilateral bloody nipple discharge in an older man[J]. Am Fam Physician, 2023, 107(5): 541-542.
3 JIWA N, KUMAR S, GANDHEWAR R, et al. Diagnostic accuracy of nipple discharge fluid cytology:a meta-analysis and systematic review of the literature[J]. Ann Surg Oncol, 2022, 29(3): 1774-1786.
4 FILIPE M D, PATULEIA S I S, VRIENS M R, et al. Meta-analysis and cost-effectiveness of ductoscopy, duct excision surgery and MRI for the diagnosis and treatment of patients with pathological nipple discharge[J]. Breast Cancer Res Treat, 2021, 186(2): 285-293.
5 LABIB M, KELLEY S O. Circulating tumor cell profiling for precision oncology[J]. Mol Oncol, 2021, 15(6): 1622-1646.
6 FINA E. Signatures of breast cancer progression in the blood: what could be learned from circulating tumor cell transcriptomes[J]. Cancers (Basel), 2022, 14(22): 5668.
7 FRIDRICHOVA I, KALINKOVA L, CIERNIKOVA S. Clinical relevancy of circulating tumor cells in breast cancer: epithelial or mesenchymal characteristics, single cells or clusters?[J]. Int J Mol Sci, 2022, 23(20): 12141.
8 田益次郎, 難波清, 青山英子, 等. 異常乳頭分泌症例における乳管内病変の内視鏡診断―乳管内視鏡分類について[J]. 乳癌の臨床, 1996, 11: 134-141.
9 LEBEAU A. Updated WHO classification of tumors of the breast[J]. Pathologe, 2021, 42():155-159.
10 LI X Q, XU F, LEI C Q, et al. Accuracy for cytological evaluation in the detection of breast cancer among patients with pathologic nipple discharge: a PRISMA-compliant meta-analysis[J]. Chin Med J (Engl), 2020, 133(4): 435-443.
11 HARRIS L, FRITSCHE H, MENNEL R, et al. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer[J]. J Clin Oncol, 2007, 25(33): 5287-5312.
12 孙婧怡, 马礼兵. 循环肿瘤细胞在肺癌诊疗中的临床应用与进展[J]. 实用医学杂志, 2018, 34(23):3846-3848, 3853.
13 中国抗癌协会乳腺癌专业委员会. 中国晚期乳腺癌临床诊疗专家共识(2018 版)[J]. 中华肿瘤杂志, 2018, 40(9): 703-713.
14 DIANAT-MOGHADAM H, AZIZI M, ESLAMI-S Z, et al. The role of circulating tumor cells in the metastatic cascade: biology, technical challenges, and clinical relevance[J]. Cancers (Basel), 2020, 12(4): 867.
15 华红, 郝贵亮, 王清玲, 等. 外周血循环肿瘤细胞监测在乳腺癌术后转移早期诊断中的应用[J]. 山东医药, 2019, 59(11): 56-58.
16 赵晓慧, 李爽. 循环肿瘤细胞、微小RNA-196a、肿瘤特异性生长因子在宫颈癌中的表达及与临床病理特征和预后的关系[J]. 安徽医药, 2023, 27(4):814-818.
17 ADDANKI S, MEAS S, SARLI V N, et al. Applications of circulating tumor cells and circulating tumor DNA in precision oncology for breast cancers[J]. Int J Mol Sci, 2022, 23(14): 7843.
18 王鑫羊, 夏添松. 循环肿瘤细胞在转移性乳腺癌中的应用[J]. 南京医科大学学报(自然科学版), 2022, 42(1): 142-146.
19 刘涛, 郑玉菡, 陈宝英, 等.乳腺癌CTC分型与临床病理特征相关性探讨[J]. 深圳中西医结合杂志, 2019,29(19):1-3, 封3.
20 WAAIJER L, FILIPE M D, SIMONS J, et al. Detection of breast cancer precursor lesions by autofluorescence ductoscopy[J]. Breast Cancer, 2021, 28(1): 119-129.
21 李智, 史立晖, 张璐, 等. 纤维乳管镜和乳腺超声在乳管占位性病变的诊治价值研究[J]. 中华保健医学杂志, 2021, 23(2):181-182.
22 杨舒涵, 温健, 窦怀豹, 等. 乳管镜对以病理性乳头溢液为首发症状乳腺癌诊断价值分析[J]. 中国实用外科杂志, 2020, 40(10): 1159-1162.
23 XU F, ZHU C, WANG Z H, et al. Deep learning for real-time detection of breast cancer presenting pathological nipple discharge by ductoscopy[J]. Front Oncol, 2023, 13(1): 1103145.
24 MAKINELI S, FILIPE M D, EUWE F, et al. Feasibility of narrow-band imaging, intraductal biopsy, and laser ablation during mammary ductoscopy: protocol for an interventional study[J]. Int J Surg Protoc, 2022, 26(1): 73-80.
25 CONGIUSTA A, BROWN A, BROWN A M, et al. Intraoperative pancreatic ductoscopy for ampullary adenocarcinoma during pancreatic resection: a case report[J]. J Pancreat Cancer, 2019, 5(1): 58-61.
文章导航

/